Axsome Therapeutics (AXSM) Current Taxes (2024 - 2026)
Axsome Therapeutics (AXSM) posted Current Taxes of $99000.0 for Q1 2026, down 1.98% sequentially from $101000.0 in Q4 2025, and down 89.69% YoY from $960000.0 in Q1 2025.
Analysis
Axsome Therapeutics (AXSM) Current Taxes (2024 - 2026) Analysis & Trends
Axsome Therapeutics has reported Current Taxes for 3 years, with the latest figure at $99000.0 in Q1 2026.
- Quarterly Current Taxes fell 89.69% year-over-year to $99000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $99000.0 (down 89.69% YoY) and the FY2025 annual result came in at $101000.0, down 89.48% from the prior year.
- Current Taxes declined to $99000.0 in Q1 2026 per AXSM's latest filing, from $101000.0 in the prior quarter.
- Over five years, Current Taxes peaked at $960000.0 in Q4 2024 and troughed at $99000.0 in Q1 2026.
- A 3-year average of $514000.0 and a median of $493000.0 in 2024 frame the typical range for Current Taxes.
- The sharpest annual moves came in 2025 and 2026: Current Taxes jumped 95.12% in 2025, then plunged 89.69% in 2026.
- Over 3 years, Current Taxes stood at $960000.0 in 2024, then plunged by 89.48% to $101000.0 in 2025, then slipped by 1.98% to $99000.0 in 2026.
- According to Business Quant data, Current Taxes over the past three periods registered $99000.0, $101000.0, and $960000.0 for Q1 2026, Q4 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 76.32 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Axsome Therapeutics | 10.75 Bn | 10.43 Bn | 204.81 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 99,000.00 |
| Dec 31, 2025 | 101,000.00 |
| Mar 31, 2025 | 960,000.00 |
| Dec 31, 2024 | 960,000.00 |
| Sep 30, 2024 | 493,000.00 |
| Jun 30, 2024 | 493,000.00 |
| Mar 31, 2024 | 492,000.00 |